Medtronic's Symplicity Spyral RDN System Evaluated for Time-to-Target Range in SPYRAL HTN-ON MED and GSR-DEFINE

May 17, 2022—Medtronic announced data showing the benefits of the Symplicity blood pressure (BP) procedure with the company’s Symplicity S

Related Keywords

Germany ,Georgia ,United States ,Japan ,Piedmont ,Paris ,France General ,France ,Saarland ,Atlanta ,Washington ,Canada ,Symplicity Spyral ,Felix Mahfoud ,David Kandzari ,Cardiovascular Services In Atlanta ,Cardiologist At Saarland University Hospital In Homburg ,American College Of Cardiology ,Piedmont Heart Institute ,Medtronic ,American College ,Principal Investigator David Kandzari ,Cardiovascular Services ,Saarland University Hospital ,Symplicity ,Blood Pressure ,P ,Renal Denervation ,Cdn ,Pyral Htn On Med ,Sr Define ,Late Breaking Clinical Trials ,Uropcr 2022 ,Radiofrequency ,Antihypertensive ,Cc 22 ,Hypertension ,